{"id":"https://openalex.org/W2125636670","doi":"https://doi.org/10.1002/jps.10336","title":"Timed\u2010release formulation to avoid drug\u2013drug interaction between diltiazem and midazolam","display_name":"Timed\u2010release formulation to avoid drug\u2013drug interaction between diltiazem and midazolam","publication_year":2003,"publication_date":"2003-03-24","ids":{"openalex":"https://openalex.org/W2125636670","doi":"https://doi.org/10.1002/jps.10336","mag":"2125636670","pmid":"https://pubmed.ncbi.nlm.nih.gov/12661064"},"language":"en","primary_location":{"id":"doi:10.1002/jps.10336","doi":"https://doi.org/10.1002/jps.10336","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.10336","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019040622","display_name":"Toyohiro Sawada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Toyohiro Sawada","raw_affiliation_strings":["DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425-0072, Japan. sawada_t@yamanouchi.co.jp","DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425-0072, Japan. sawada_t@yamanouchi.co.jp","institution_ids":[]},{"raw_affiliation_string":"DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004653171","display_name":"Kazuhiro Sako","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kazuhiro Sako","raw_affiliation_strings":["DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075062625","display_name":"Keiichi Yoshihara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keiichi Yoshihara","raw_affiliation_strings":["DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111637229","display_name":"Katsutoshi Nakamura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katsutoshi Nakamura","raw_affiliation_strings":["Pharmaceutical Technology Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Technology Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012993555","display_name":"Shigeharu Yokohama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shigeharu Yokohama","raw_affiliation_strings":["DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"DDS Research, Novel Pharmaceutical Research Laboratories, Yamanouchi Pharmaceutical Company, Ltd., 180 Ozumi, Yaizu, Shizuoka 425\u20100072, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051956583","display_name":"Masahiro Hayashi","orcid":"https://orcid.org/0000-0002-1674-4093","observed_orcids":["https://orcid.org/0000-0002-1674-4093"]},"institutions":[{"id":"https://openalex.org/I149964584","display_name":"Tokyo University of Pharmacy and Life Sciences","ror":"https://ror.org/057jm7w82","country_code":"JP","type":"education","lineage":["https://openalex.org/I149964584"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masahiro Hayashi","raw_affiliation_strings":["Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Science, 1432\u20101 Horinouchi, Hachioji, Tokyo 192\u20100392, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Science, 1432\u20101 Horinouchi, Hachioji, Tokyo 192\u20100392, Japan","institution_ids":["https://openalex.org/I149964584"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019040622"],"corresponding_institution_ids":[],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":1.2634,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.77130486,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"92","issue":"4","first_page":"790","last_page":"797"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9282000064849854,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diltiazem","display_name":"diltiazem","score":0.8659999966621399},{"id":"https://openalex.org/keywords/midazolam","display_name":"midazolam","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9200000166893005},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8109999895095825},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.5789999961853027},{"id":"https://openalex.org/keywords/plasma-concentration-time-curve","display_name":"plasma concentration-time curve","score":0.6679999828338623},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.6340000033378601}],"concepts":[{"id":"https://openalex.org/C2776741139","wikidata":"https://www.wikidata.org/wiki/Q422229","display_name":"Diltiazem","level":3,"score":0.9748729467391968},{"id":"https://openalex.org/C2778000748","wikidata":"https://www.wikidata.org/wiki/Q423071","display_name":"Midazolam","level":3,"score":0.7864201068878174},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7379894256591797},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6685519218444824},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5744388103485107},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.556954562664032},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4943850040435791},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.46703100204467773},{"id":"https://openalex.org/C2909111407","wikidata":"https://www.wikidata.org/wiki/Q422229","display_name":"Diltiazem hydrochloride","level":4,"score":0.4396373927593231},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4215278923511505},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3571816086769104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12433663010597229},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.08895626664161682},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.04950389266014099},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008874","descriptor_name":"Midazolam","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019999","descriptor_name":"Pharmaceutical Solutions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/jps.10336","doi":"https://doi.org/10.1002/jps.10336","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.10336","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:12661064","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12661064","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1531474084","https://openalex.org/W1558112674","https://openalex.org/W1564120434","https://openalex.org/W1586087180","https://openalex.org/W1892194801","https://openalex.org/W1895274337","https://openalex.org/W1929292775","https://openalex.org/W1973354707","https://openalex.org/W1985419749","https://openalex.org/W1988346389","https://openalex.org/W2002407258","https://openalex.org/W2010886476","https://openalex.org/W2020864131","https://openalex.org/W2022713088","https://openalex.org/W2024587809","https://openalex.org/W2035975170","https://openalex.org/W2049451933","https://openalex.org/W2050637949","https://openalex.org/W2055976655","https://openalex.org/W2056143433","https://openalex.org/W2062498960","https://openalex.org/W2073965718","https://openalex.org/W2082314577","https://openalex.org/W2082453607","https://openalex.org/W2082979826","https://openalex.org/W2084538818","https://openalex.org/W2085444179","https://openalex.org/W2097502628","https://openalex.org/W2145879423","https://openalex.org/W2155268095","https://openalex.org/W2162740038","https://openalex.org/W2317759605","https://openalex.org/W4248512491","https://openalex.org/W6633265384","https://openalex.org/W6640278148","https://openalex.org/W6682576693"],"related_works":["https://openalex.org/W2105664653","https://openalex.org/W2082314577","https://openalex.org/W2074999857","https://openalex.org/W1985419749","https://openalex.org/W2021824652","https://openalex.org/W4300344882","https://openalex.org/W2021580155","https://openalex.org/W4248020547","https://openalex.org/W2162946847","https://openalex.org/W4300535288"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}